Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed an algorithm for self-diagnosing scalp conditions with high accuracy using smart device-attached microscopes.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

COVID-19 vaccination may be linked to alopecia areata, especially in young adults.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alefacept showed some effectiveness for alopecia areata but needs more research.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

Low dose valproic acid treatment caused hair loss in a young patient.

Unani medicine helped regrow eyebrow hair in 45 days.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

People with alopecia areata have higher insulin resistance.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Alopecia areata involves immune response and gene changes affecting hair loss.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Oral Apremilast effectively treats alopecia areata in most patients.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

The summit aimed to speed up finding treatments for alopecia areata.

Current treatments for alopecia show no significant long-term benefits.